About
Who We Are
Management Team
Scientific Advisors
Board of Directors
Pipeline & Research
Pipeline
Plinabulin
Protein Degradation
Other Pipeline
Posters & Publications
Collaborations
Expanded Access Policy
NEWS & MEDIA
Investors
Stock Overview
Events & Presentations
Financials & Filings
ESG
Corporate Governance
Careers
Contact Us
Select Page
BeyondSpring Inc. Data Call
September 21, 2021
09.20.2021
BeyondSpring Inc. Data Call
View webcast
Search for:
RECENT NEWS ARTICLES
BeyondSpring Receives Notifications from Nasdaq Regarding Compliance With Listing Rules
BeyondSpring Presents Positive Data with Plinabulin for the Prevention of Docetaxel-Induced Neutropenia in Patients with Non-Small Cell Lung Cancer and Breast Cancer at Three Medical Conferences
BeyondSpring Receives Nasdaq Notice Regarding Minimum Bid Price Requirements
BeyondSpring Presents New Clinical Evidence of Plinabulin Protection of Granulocyte-Monocyte Progenitor Stem Cells for the Prevention of Chemotherapy-Induced Neutropenia at the ESMO Congress 2022
BeyondSpring Presents New Data for the Use of Plinabulin and Pegfilgrastim to Decrease Neutropenia Burden in Peri-Transplant Multiple Myeloma Patients at the 19th International Myeloma Society Annual Meeting
BeyondSpring Presents New Clinical Data in the Chemotherapy-Induced Neutropenia and NSCLC Programs at the 2022 ASCO Annual Meeting
BeyondSpring Announces Three Poster Presentations at the American Society of Clinical Oncology (ASCO) Annual Meeting
BeyondSpring Files 2021 Annual Report on Form 20-F
BeyondSpring Announces Fourth Quarter and Year End 2021 Financial Results and Provides a Corporate Update
BeyondSpring to Announce Fourth Quarter and Year End 2021 Financial Results and Host a Conference Call on Thursday, April 14, 2022
RECENT MEDIA COVERAGE
TD Ameritrade Watch List
Managing Chemotherapy Toxicities for Improved Patient Outcomes
New Treatment Modalities: Protein Degraders And Molecular Glues Gain Traction
Seed Therapeutics blossoms in an $800M deal with Lilly
Seed Therapeutics Launches Protein Degradation Research Platform and Appoints Edward Dongheng Liu as Chief Financial Officer
BeyondSpring Forms Partnership Advisory Committee Comprised of Industry Veterans
JAMA Oncology Highlights Plinabulin’s Efficacy in Preventing Chemotherapy-Induced Neutropenia as a Monotherapy
Pegfilgrastim Plus Plinabulin Reduces Chemo-Induced Neutropenia in TAC-Treated Patients
Dr. Lan Huang Featured in Nature Titled “‘Innovation’ Nation”
Woman of the Week Podcast: Dr. Lan Huang, Co-founder, Chairman and Chief Executive Officer BeyondSpring
We use cookies to ensure that we give you the best experience on our website. Please click “OK” to continue or read our Privacy & Cookie Policy.
Ok
Privacy policy
